Clinical Trial Update: Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TRC101 for slowing progression of chronic kidney disease in patients with metabolic acidosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Metabolic Acidosis

Drugs mentioned

• TRC101 (TRC101)

Snippet

Sponsor: Tricida, Inc. | Conditions: Metabolic Acidosis, Chronic Kidney Disease | Phase 3 | Status: TERMINATED